The Association of Smoking Status with Diabetic Microvascular Complications in Korean Patients with Type 2 Diabetes
3
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Few studies have investigated the association between smoking and microvascular complications in the Asian population with type 2 diabetes mellitus (T2DM). We aimed to investigate the relationship between smoking status and microvascular complications in Korean patients with T2DM. Materials and Methods: From the Korean National Diabetes Program cohort, we included 2316 Korean male with T2DM who had baseline clinical information available, including their smoking status, and underwent diabetic complication studies. Results: Compared to non-smokers, current smokers had higher odds of any-microvascular complications [adjusted odds ratio (aOR) 1.45, 95% confidence interval (CI) 1.07–1.97, p=0.016]. The odds of neuropathy were significantly higher; however, the odds of retinopathy were significantly lower in current smokers than in nonsmokers (all p<0.05). Among those who underwent repeated complication tests after 3 years, the risk of newly developed retinopathy was significantly increased in ex-smokers [aOR 3.77 (95% CI 1.61–8.87), p=0.002]. Within ex-smokers, long smoking duration and smoking cessation within the recent 5 years were associated with an increased risk of newly developed retinopathy (all p<0.05). Conclusion: Male smokers had higher odds of having overall diabetic microvascular complications, including neuropathy. However, the odds of having retinopathy were significantly lower among current smokers. More attention and research are needed regarding the increased risk of retinopathy development in ex-smokers who have recently stopped smoking after a long history of smoking.
Abstract
Purpose: Few studies have investigated the association between smoking and microvascular complications in the Asian population with type 2 diabetes mellitus (T2DM). We aimed to investigate the relationship between smoking status and microvascular complications in Korean patients with T2DM. Materials and Methods: From the Korean National Diabetes Program cohort, we included 2316 Korean male with T2DM who had baseline clinical information available, including their smoking status, and underwent diabetic complication studies. Results: Compared to non-smokers, current smokers had higher odds of any-microvascular complications [adjusted odds ratio (aOR) 1.45, 95% confidence interval (CI) 1.07–1.97, p=0.016]. The odds of neuropathy were significantly higher; however, the odds of retinopathy were significantly lower in current smokers than in nonsmokers (all p<0.05). Among those who underwent repeated complication tests after 3 years, the risk of newly developed retinopathy was significantly increased in ex-smokers [aOR 3.77 (95% CI 1.61–8.87), p=0.002]. Within ex-smokers, long smoking duration and smoking cessation within the recent 5 years were associated with an increased risk of newly developed retinopathy (all p<0.05). Conclusion: Male smokers had higher odds of having overall diabetic microvascular complications, including neuropathy. However, the odds of having retinopathy were significantly lower among current smokers. More attention and research are needed regarding the increased risk of retinopathy development in ex-smokers who have recently stopped smoking after a long history of smoking.
참고문헌 (39)
- Dal Canto E, "Diabetes as a cardiovascular risk factor : an overview of global trends of macro and micro vascular complications", Eur J Prev Cardiol, 26(2 suppl), pp.25~32 (2019)
- Messner B, "Smoking and cardiovascular disease : mechanisms of endothelial dysfunction and early atherogenesis", Arterioscler Thromb Vasc Biol, 34, pp.509~515 (2014)
- Turner RC, "Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus : United Kingdom Prospective Diabetes Study(UKPDS : 23)", BMJ, 316, pp.823~828 (1998)
- Al-Delaimy WK, "Smoking and mortality among women with type 2 diabetes : the nurses’ health study cohort", Diabetes Care, 24, pp.2043~2048 (2001)
- Zhou JF, "Effects of cigarette smoking and smoking cessation on plasma constituents and enzyme activities related to oxidative stress", Biomed Environ Sci, 13, pp.44~55 (2000)
- Morrow JD, "Increase in circulating products of lipid peroxidation(F2-isoprostanes)in smokers. Smoking as a cause of oxidative damage", N Engl J Med, 332, pp.1198~1203 (1995)
- Christiansen JS, "Cigarette smoking and prevalence of microangiopathy in juvenile-onset insulin-dependent diabetes mellitus", Diabetes Care, 1, pp.146~149 (1978)
- Ikeda Y, "Effect of smoking on the prevalence of albuminuria in Japanese men with non-insulin-dependent diabetes mellitus", Diabetes Res Clin Pract, 36, pp.57~61 (1997)
- Sawicki PT, "Smoking is associated with progression of diabetic nephropathy", Diabetes Care, 17, pp.126~131 (1994)
- Liao D, "Cigarette smoking as a risk factor for diabetic nephropathy : a systematic review and meta-analysis of prospective cohort studies", PLoS One, 14, pp.e0210213~ (2019)
- Mitchell BD, "Cigarette smoking and neuropathy in diabetic patients", Diabetes Care, 13, pp.434~437 (1990)
- Moss SE, "Cigarette smoking and ten-year progression of diabetic retinopathy", Ophthalmology, 103, pp.1438~1442 (1996)
- Cai X, "The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes : a meta-analysis", Endocrine, 62, pp.299~306 (2018)
- Rhee SY, "Prevalence of chronic complications in Korean patients with type 2 diabetes mellitus based on the Korean national diabetes program", Diabetes Metab J, 35, pp.504~512 (2011)
- American Diabetes Association, "2. Classification and diagnosis of diabetes : standards of medical care in diabetes—2021", Diabetes Care, 44(Suppl 1), pp.S15~S33 (2021)
- Levey AS, "A more accurate method to estimate glomerular filtration rate from serum creatinine : a new prediction equation", Ann Intern Med, 130, pp.461~470 (1999)
- Levey AS, "A new equation to estimate glomerular filtration rate", Ann Intern Med, 150, pp.604~612 (2009)
- Matthews DR, "Homeostasis model assessment : insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man", Diabetologia, 28, pp.412~419 (1985)
- Inker LA, "KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD", Am J Kidney Dis, 63, pp.713~735 (2014)
- Park SY, "Dietary glutamic acid and aspartic acid as biomarkers for predicting diabetic retinopathy", Sci Rep, 11, pp.7244~ (2021)
- Meijer JW, "Symptom scoring systems to diagnose distal polyneuropathy in diabetes : the diabetic neuropathy symptom score", Diabet Med, 19, pp.962~965 (2002)
- Mythili A, "A comparative study of examination scores and quantitative sensory testing in diagnosis of diabetic polyneuropathy", Int J Diabetes Dev Ctries, 30, pp.43~48 (2010)
- Qin R, "Excess risk of mortality and cardiovascular events associated with smoking among patients with diabetes : meta-analysis of observational prospective studies", Int J Cardiol, 167, pp.342~350 (2013)
- Liu X, "The risk factors for diabetic peripheral neuropathy : a meta-analysis", PLoS One, 14, pp.e0212574~ (2019)
- Tesfaye S, "Vascular risk factors and diabetic neuropathy", N Engl J Med, 352, pp.341~350 (2005)
- Szwarcbard N, "The association of smoking status with glycemic control, metabolic profile and diabetic complications–results of the Australian National Diabetes Audit(ANDA)", J Diabetes Complications, 34, pp.107626~ (2020)
- Stratton IM, "UKPDS 50 : risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis", Diabetologia, 44, pp.156~163 (2001)
- Gange WS, "Incidence of proliferative diabetic retinopathy and other neovascular sequelae at 5 years following diagnosis of type 2 diabetes", Diabetes Care, 44, pp.2518~2526 (2021)
- Park SK, "Changes in smoking status, amount of smoking and their relation to the risk of microvascular complications in men with diabetes mellitus", Diabetes Metab Res Rev, 39, pp.e3697~ (2023)
- Zhong ZL, "Risk factors associated with retinal neovascularization of diabetic retinopathy in type 2 diabetes mellitus", Int J Ophthalmol, 4, pp.182~185 (2011)
- Omae T, "Effects of habitual cigarette smoking on retinal circulation in patients with type 2 diabetes", Invest Ophthalmol Vis Sci, 57, pp.1345~1351 (2016)
- Chase HP, "Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes", JAMA, 265, pp.614~617 (1991)
- Savage S, "Clinical factors associated with urinary albumin excretion in type II diabetes", Am J Kidney Dis, 25, pp.836~844 (1995)
- Klein R, "Ten-year incidence of gross proteinuria in people with diabetes", Diabetes, 44, pp.916~923 (1995)
- Yokoyama H, "Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients", Diabetologia, 40, pp.405~411 (1997)
- Ritz E, "Acute effects of cigarette smoking on renal hemodynamics", Contrib Nephrol, 130, pp.31~38 (2000)
- Cooper RG, "Effect of tobacco smoking on renal function", Indian J Med Res, 124, pp.261~268 (2006)
- Baggio B, "Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients", J Am Soc Nephrol, 13, pp.2730~2736 (2002)
- Kar D, "Association of smoking and cardiometabolic parameters with albuminuria in people with type 2 diabetes mellitus : a systematic review and meta-analysis", Acta Diabetol, 56, pp.839~850 (2019)